ELITE PHARMACEUTICALS INC /NV/ Quarterly Debt-to-equity in % from Q4 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Elite Pharmaceuticals Inc /Nv/ quarterly Debt-to-equity history and growth rate from Q4 2011 to Q3 2024.
  • Elite Pharmaceuticals Inc /Nv/ Debt-to-equity for the quarter ending September 30, 2024 was 59.6 %, a 4.69% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 59.6 +2.67 +4.69% Sep 30, 2024
Q2 2024 52.9 -10.7 -16.9% Jun 30, 2024
Q1 2024 53.8 -17.9 -25% Mar 31, 2024
Q4 2023 54.6 -17.7 -24.5% Dec 31, 2023
Q3 2023 56.9 -7.41 -11.5% Sep 30, 2023
Q2 2023 63.6 +8.5 +15.4% Jun 30, 2023
Q1 2023 71.7 +25.3 +54.4% Mar 31, 2023
Q4 2022 72.3 +20.4 +39.2% Dec 31, 2022
Q3 2022 64.3 +3.93 +6.51% Sep 30, 2022
Q2 2022 55.1 -15.1 -21.5% Jun 30, 2022
Q1 2022 46.4 -39.9 -46.2% Mar 31, 2022
Q4 2021 52 -51.1 -49.6% Dec 31, 2021
Q3 2021 60.4 -66 -52.2% Sep 30, 2021
Q2 2021 70.1 -134 -65.6% Jun 30, 2021
Q1 2021 86.3 -280 -76.4% Mar 31, 2021
Q4 2020 103 -3.1K -96.8% Dec 31, 2020
Q3 2020 126 +785 Sep 30, 2020
Q2 2020 204 +1.94K Jun 30, 2020
Q1 2020 366 -1.98K -84.4% Mar 31, 2020
Q4 2019 3.2K +2.68K +508% Dec 31, 2019
Q3 2019 -659 -968 -313% Sep 30, 2019
Q2 2019 -1.73K -1.97K -816% Jun 30, 2019
Q1 2019 2.34K +2.09K +813% Mar 31, 2019
Q4 2018 527 +409 +348% Dec 31, 2018
Q3 2018 310 +234 +307% Sep 30, 2018
Q2 2018 242 +181 +298% Jun 30, 2018
Q1 2018 257 +144 +128% Mar 31, 2018
Q4 2017 118 +509 Dec 31, 2017
Q3 2017 76.1 +154 Sep 30, 2017
Q2 2017 60.8 +120 Jun 30, 2017
Q1 2017 113 +179 Mar 31, 2017
Q4 2016 -391 -322 -465% Dec 31, 2016
Q3 2016 -78 +34.5 +30.6% Sep 30, 2016
Q2 2016 -58.9 +70.8 +54.6% Jun 30, 2016
Q1 2016 -66.4 +65.1 +49.5% Mar 31, 2016
Q4 2015 -69.3 +69.7 +50.1% Dec 31, 2015
Q3 2015 -112 +27.6 +19.7% Sep 30, 2015
Q2 2015 -130 +17.9 +12.1% Jun 30, 2015
Q1 2015 -131 +40.1 +23.4% Mar 31, 2015
Q4 2014 -139 +182 +56.8% Dec 31, 2014
Q3 2014 -140 +108 +43.6% Sep 30, 2014
Q2 2014 -148 +37.6 +20.3% Jun 30, 2014
Q1 2014 -172 -8.47 -5.19% Mar 31, 2014
Q4 2013 -321 -165 -105% Dec 31, 2013
Q3 2013 -248 -93.2 -60.1% Sep 30, 2013
Q2 2013 -185 -30.6 -19.8% Jun 30, 2013
Q1 2013 -163 -16.3 -11.1% Mar 31, 2013
Q4 2012 -156 -9.53 -6.49% Dec 31, 2012
Q3 2012 -155 Sep 30, 2012
Q2 2012 -155 Jun 30, 2012
Q1 2012 -147 Mar 31, 2012
Q4 2011 -147 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.